-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Both the M and N alleles encode an antigen on glycoprotein A (GPA), which is a red blood cell (RBC) surface sialoglycoprotein
.
The interaction between RBC GPA and leukocyte surface lectins may down-regulate their activation
.
The current study investigated whether RBC's autoantibodies against GPA, such as autoanti-M/N, can trigger an activated phenotype in peripheral blood leukocytes
.
.
The interaction between RBC GPA and leukocyte surface lectins may down-regulate their activation
.
The current study investigated whether RBC's autoantibodies against GPA, such as autoanti-M/N, can trigger an activated phenotype in peripheral blood leukocytes
.
Leukocyte activation was evaluated in whole blood from patients with autoanti-GPA (anti-M/N) and compared with patients with allogeneic anti-M/N and healthy subjects
.
Analysis of control samples from healthy subjects without antibodies incubated with anti-GPA or anti-Rh in vitro to determine the expression of neutrophil and monocyte surface activation markers, the content of reactive oxygen species (ROS), and the interaction with RBC The formation of aggregates
Leukocyte activation was evaluated in whole blood from patients with autoanti-GPA (anti-M/N) and compared with patients with allogeneic anti-M/N and healthy subjects
.
Analysis of control samples from healthy subjects without antibodies incubated with anti-GPA or anti-Rh in vitro to determine the expression of neutrophil and monocyte surface activation markers, the content of reactive oxygen species (ROS), and the interaction with RBC The formation of aggregates
Table 1: Characteristics of patients with autologous anti-M or allogeneic anti-M/N antibodies Table 1: Characteristics of patients with autologous anti-M or allogeneic anti-M/N antibodies
Table 2: Complete blood count (mean ± standard deviation)
Table 2: Complete blood count (mean ± standard deviation) Table 2: Complete blood count (mean ± standard deviation)Figure 1: In vivo and in vitro expression of leukocyte surface activation markers
Figure 1: In vivo and in vitro expression of leukocyte surface activation markers Figure 1: In vivo and in vitro expression of leukocyte surface activation markersFigure 2: In vitro detection of white blood cells and intracellular ROS content
Figure 2: In vitro detection of white blood cell and intracellular ROS content Figure 2: In vitro detection of white blood cell and intracellular ROS content
Figure 3: Neutrophil-erythrocyte aggregation in vitro
Figure 3: Neutrophil-erythrocyte aggregation in vitro Figure 3: Neutrophil-erythrocyte aggregation in vitroPatients with allogeneic anti-M/N (p = .
Patients with allogeneic anti-M/N (p = .
In summary, exposure of neutrophils and monocytes in peripheral blood to antibodies against GPA on the RBC surface, such as M or N antigens, may trigger an activated phenotype
In summary, exposure of neutrophils and monocytes in peripheral blood to antibodies against GPA on the RBC surface, such as M or N antigens, may trigger an activated phenotype
Original source:
Klein, MN , Larkin, EJ , Marshall, JN , Fan, X , Parry, P , Tirouvanziam, R , et al.
Klein, MN , Larkin, EJ , Marshall, JN , Fan, X , Parry, P , Tirouvanziam, R , et al.
Autoantibodies to red blood cell surface Glycophorin A impact the activation poise of circulating leukocytes .
Transfusion .
2021 ; 1 – 10 .
https://doi.
org/10.
1111/trf.
16746
Leave a message here